Regulatory Consulting
MolDX Guidance & Support
Expert guidance to navigate MolDX requirements for molecular diagnostic test coverage.
MolDX is the gateway to Medicare coverage for molecular diagnostics in many jurisdictions. Our team provides the strategic guidance and preparation support to help you successfully obtain coverage for your molecular tests.
Understanding MolDX
MolDX (Molecular Diagnostic Services Program) is a Medicare Administrative Contractor (MAC) program that manages coverage and reimbursement for molecular diagnostic tests. Administered primarily by Palmetto GBA, MolDX requirements apply in multiple MAC jurisdictions covering a significant portion of the U.S. Medicare population.
For molecular diagnostic tests—including some PCR-based testing like UTI panels—MolDX approval is often required for Medicare coverage. Without it, claims may be denied regardless of clinical utility.
The process isn't straightforward. It requires technical assessment documentation, clinical validity and utility evidence, analytical validation data, appropriate coding and billing information, and ongoing reporting. Incomplete or poorly prepared submissions lead to delays or denials—leaving tests without the coverage needed to serve patients.
MolDX Expertise From Experience
Doc Lab has direct experience navigating MolDX for our own molecular diagnostic tests. We understand the process not just theoretically, but from having been through it ourselves.
That experience translates into practical guidance: what MolDX reviewers look for, common pitfalls to avoid, how to structure documentation effectively, and how to respond when questions arise. We prepare technical assessments as a core part of that support.
We've also helped other laboratories and practices navigate MolDX requirements, giving us perspective across different tests and situations.
MolDX Support Services
Strategic Assessment
- Evaluation of your test and coverage pathway
- MolDX applicability determination
- Timeline and resource planning
- Identification of potential challenges
Technical Assessment Preparation
- Documentation of test methodology
- Analytical validation data organization
- Clinical validity evidence compilation
- Submission package preparation
DEX Registry Guidance
- Z-code application support
- Registry entry requirements
- Ongoing compliance requirements
Submission Support
- Application preparation and review
- Response to MolDX inquiries
- Communication with Palmetto GBA
- Tracking and follow-through
Compliance & Maintenance
- Understanding ongoing reporting requirements
- Maintaining coverage status
- Addressing coverage changes or challenges
When to Engage MolDX Support
-
New molecular test launch
If you're offering a new molecular diagnostic test, MolDX approval may be required for Medicare coverage in applicable jurisdictions.
-
Coverage challenges
If you're experiencing claim denials related to MolDX coverage, we can help evaluate the situation and develop a path forward.
-
Expanding to MolDX jurisdictions
If you're currently offering testing in non-MolDX states and want to expand coverage, we can guide you through the process.
-
Understanding requirements
If you're unsure whether MolDX applies to your testing or what the process involves, consultation can provide clarity.
MolDX Status of Doc Lab Tests
-
UTI Express™
Currently available nationwide, including MolDX-restricted states.
-
UTI Max
Currently available in non-MolDX states, with a MolDX application pending. Contact us for the latest status in your jurisdiction.
Common Questions
Does MolDX apply to all molecular tests?
MolDX requirements apply to molecular diagnostic tests in jurisdictions administered by participating MACs (primarily Palmetto GBA's JJ and JM jurisdictions, plus MCS's jurisdiction). Not all molecular tests require MolDX, and requirements may vary—we can help you determine applicability.
How long does MolDX approval take?
Timeline varies based on test complexity, documentation completeness, and MolDX workload. Proper preparation helps avoid delays from incomplete submissions. Contact us to discuss what to expect for your specific situation.
Can you help with tests not developed by Doc Lab?
Yes. Our MolDX guidance services are available for molecular diagnostic tests beyond our own portfolio. We apply the same expertise regardless of test origin.
What if our MolDX application was denied?
We can review the denial, identify issues, and help develop a strategy for addressing MolDX concerns—whether through additional documentation, resubmission, or reconsideration.
Is MolDX the same as FDA clearance?
No. MolDX is a Medicare coverage program; FDA clearance is a separate regulatory process. A test can be FDA-cleared but still require MolDX approval for Medicare coverage, or vice versa. We also offer FDA Regulatory Consulting if needed.
Let's talk
Questions About MolDX?
Whether you're launching a new molecular test, experiencing coverage challenges, or just trying to understand MolDX requirements, let's talk.